Trademarkia Logo

Canada

C$
LUXEMPLI
REGISTERED

on 19 Nov 2019

Last Applicant/ Owned by

JOHNSON & JOHNSON

One Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001

US

Serial Number

1838063 filed on 17th May 2017

Registration Number

TMA1063552 registered on 19th Nov 2019

Registration expiry Date

19th Nov 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

LUXEMPLI

Trademark usage description

human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases Read More

Classification Information


Class [005]
Human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-viral medications; anti-inflammatory medications; anti-pain medications; and anti-infective medications; human vaccines


Classification kind code

11

Mark Details


Serial Number

1838063

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 8th Feb 2019
Allowed
Submitted for opposition 71
on 7th Feb 2019
Opposition Removed
Submitted for opposition 110
on 12th Oct 2018
Proposed Opposition
Submitted for opposition 42
on 8th Aug 2018
Advertised
Submitted for opposition 26
on 19th Jul 2018
Approved
Submitted for opposition 22
on 29th May 2018
Search Recorded
Submitted for opposition 27
on 29th May 2018
Approval Notice Sent
Submitted for opposition 31
on 24th May 2017
Formalized
Submitted for opposition 30
on 17th May 2017
Filed
Submitted for opposition 1
on 17th May 2017
Created